Sotabase

Career

· Graduate Research Intern, National Renewable Energy Laboratory (NREL)2014–
· Engineering Intern, Washington State University: Tri-Cities2014–2014
· Technical Intern, Materials & Structures Performance Group, Pacific Northwest National Laboratory (PNNL)2013–2014
· Engineering Peer Mentor, Washington State University: Tri-Cities2013–2013
· D4 Project Engineering Intern, Washington Closure Hanford2012–

Publications (142)

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
Nature Medicine · 1996
769
cited
Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome.
Cancer Research · 1993
646
cited
Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology.
Pharmacogenetics (London) · 1995
257
cited
SERUM-HIGH-DENSITY-LIPOPROTEIN AND ATHEROSCLEROTIC HEART-DISEASE
The Lancet · 1976
224
cited
TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domains
Genes, Chromosomes and Cancer · 1995
202
cited
Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.
Proceedings of the National Academy of Sciences of the United States of America · 1991
199
cited
Screening for germ line TP53 mutations in breast cancer patients.
Cancer Research · 1992
199
cited
Human CYP1A1 (cytochrome P(1)450) gene: lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population.
Pharmacogenetics (London) · 1991
189
cited
Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas.
Human Molecular Genetics · 1995
174
cited
Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility
Human Genetics · 1994
148
cited
p53 abnormalities in different subtypes of human sarcomas.
Cancer Research · 1993
144
cited
Breast cancer and other cancers in Norwegian families with ataxia‐telangiectasia
Genes, Chromosomes and Cancer · 1990
129
cited
Familial testicular cancer in Norway and southern Sweden.
British Journal of Cancer · 1996
125
cited
Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.
British Journal of Cancer · 1996
114
cited
Detection of point mutations in the p53 gene: Comparison of single‐strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniques
Human Mutation · 1993
108
cited
Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas
Genes, Chromosomes and Cancer · 1992
108
cited
Deletion of 1p loci and microsatellite instability in colorectal polyps
Genes, Chromosomes and Cancer · 1995
104
cited
Loss of 3p or 11p alleles is associated with testicular cancer tumors.
Genomics · 1989
103
cited
Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
Proceedings of the National Academy of Sciences of the United States of America · 1992
97
cited
Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy.
British Journal of Cancer · 1990
95
cited
Sotabase